{
    "clinical_study": {
        "@rank": "102355", 
        "arm_group": {
            "arm_group_label": "Assessment", 
            "description": "All subjects will receive same assessments."
        }, 
        "brief_summary": {
            "textblock": "The present study will evaluate the long term effects on scar formation for\n      dermatome-induced skin wounds treated with Collagenase Santyl\u00ae Ointment or vehicle (white\n      petrolatum ointment) alone. The previous study, 017-101-09-001, utilized a small,\n      experimental, cutaneous wound to evaluate both time to complete wound closure and quality of\n      the resulting scar when Collagenase Santyl\u00ae Ointment was used to treat the wound."
        }, 
        "brief_title": "Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Follow up to Acute Wound Scar Study", 
        "condition_browse": {
            "mesh_term": "Cicatrix"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects will be considered qualified for enrollment if they participated in the\n             Collagenase Santyl\u00ae Ointment Study 017 101-09-001 and provide written informed\n             consent.\n\n          -  The informed consent document must be read, signed, and dated by the suubject before\n             conducting any study procedures or exams. In addition, the informed consent document\n             must be signed and dated by the individual who consents the subject.  A photocopy of\n             the signed informed consent document must be provided to the subject and the original\n             signed document placed in the subject's chart.\n\n          -  Subject participated in the 017-101-09-001 study and received at least one\n             application of a test article, whether Collagenase Santyl\u00ae Ointment or White\n             Petrolatum.\n\n        Exclusion Criteria:\n\n          -  N/A"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Healthy adult volunteers who were previously treated in study 017-101-09-001 with\n        Collagenase Santyl Ointment and Vehicle (white petrolatum ointment)."
            }
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01705860", 
            "org_study_id": "017-101-09-032"
        }, 
        "intervention": {
            "arm_group_label": "Assessment", 
            "intervention_name": "Santyl", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Collagen, collagenase, scar", 
        "lastchanged_date": "April 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dallas", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "75390"
                }
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Long Term Follow-Up to Study 017-101-09-001: Effect of Collagenase Santyl\u00ae Ointment vs. Placebo on Healing and Scarring Characteristics of 600um Dermatome Wounds", 
        "overall_official": [
            {
                "affiliation": "Healthpoint", 
                "last_name": "Herbert B Slade, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Texas Southwestern Medical Center", 
                "last_name": "Shai Rozen, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Vancouver Scar Scale assessment of dermatome wounds previously treated with Santyl Ointment or White Petrolatum", 
            "measure": "Scar Assessment", 
            "safety_issue": "No", 
            "time_frame": "1 Day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01705860"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Quality of scars over time will be assessed with the BTC-2000 instrument assessment", 
            "measure": "Scar Quality", 
            "safety_issue": "No", 
            "time_frame": "1 Day"
        }, 
        "source": "Healthpoint", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Healthpoint", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}